Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces NDA For Sulbactam-Durlobactam Granted Priority Review By China's NMPA

Jan 30 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB ANNOUNCES NDA FOR SULBACTAM-DURLOBACTAM (SUL-DUR)
GRANTED PRIORITY REVIEW BY CHINA’S NMPA

Source text for Eikon:  ID:nGNX3nyb4r 
Further company coverage:  9688.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news